Verastem (VSTM) Amortizatization of Intangibles (2014 - 2026)
Verastem's quarterly Amortizatization of Intangibles came in at $279000.0 in Q1 2026, little changed quarter-over-quarter from $280000.0 in Q4 2025.
Verastem has reported Amortizatization of Intangibles for 9 years, with the latest figure at $279000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $279000.0; the trailing twelve-month figure through Mar 2026 stood at $849000.0 (changed N/A YoY), and the FY2025 full-year result was $698000.0, changed N/A from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $279000.0, roughly flat from $280000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $290000.0 in Q3 2025, with the low at $279000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 279,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 279,000.00 |
| Mar 31, 2026 | 279,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Mar 31, 2020 | 392,000.00 |
| Mar 31, 2020 | 392,000.00 |
| Dec 31, 2019 | 392,000.00 |
| Dec 31, 2019 | 392,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Mar 31, 2019 | 392,000.00 |
| Mar 31, 2019 | 392,000.00 |
| Dec 31, 2018 | 392,000.00 |
| Dec 31, 2018 | 392,000.00 |
| Sep 30, 2018 | 31,000.00 |
| Sep 30, 2018 | 31,000.00 |
| Jun 30, 2018 | 95,000.00 |
| Jun 30, 2018 | 95,000.00 |
| Mar 31, 2018 | 83,000.00 |
| Mar 31, 2018 | 83,000.00 |
| Dec 31, 2017 | 53,000.00 |
| Dec 31, 2017 | 53,000.00 |
| Sep 30, 2017 | 65,000.00 |
| Sep 30, 2017 | 65,000.00 |
| Jun 30, 2017 | 59,000.00 |
| Jun 30, 2017 | 59,000.00 |
| Mar 31, 2017 | 46,000.00 |
| Mar 31, 2017 | 46,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | -50,000.00 |
| Sep 30, 2016 | -50,000.00 |
| Jun 30, 2016 | -80,000.00 |
| Jun 30, 2016 | -80,000.00 |
| Mar 31, 2016 | -12,000.00 |
| Mar 31, 2016 | -12,000.00 |
| Dec 31, 2015 | 478,000.00 |
| Dec 31, 2015 | 478,000.00 |
| Sep 30, 2015 | -79,000.00 |
| Sep 30, 2015 | -79,000.00 |
| Jun 30, 2015 | -77,000.00 |
| Jun 30, 2015 | -77,000.00 |
| Mar 31, 2015 | -58,000.00 |
| Mar 31, 2015 | -58,000.00 |
| Dec 31, 2014 | -60,000.00 |
| Dec 31, 2014 | -60,000.00 |
| Sep 30, 2014 | -78,000.00 |
| Sep 30, 2014 | -78,000.00 |